| 99.85 0.18 (0.18%) | 03-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 120.01  |
1-year : | 124.97 |
| Resists | First : | 102.74 |
Second : | 107 |
| Pivot price | 101.23 |
|||
| Supports | First : | 95.87 | Second : | 79.76 |
| MAs | MA(5) : | 100.73  |
MA(20) : | 101.24 |
| MA(100) : | 95.11 |
MA(250) : | 74.77 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 44 |
D(3) : | 47.7 |
| RSI | RSI(14): 48.2 |
|||
| 52-week | High : | 107.69 | Low : | 46.78 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ IRMD ] has closed above bottom band by 33.1%. Bollinger Bands are 13.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 101.41 - 101.82 | 101.82 - 102.16 |
| Low: | 97.04 - 97.53 | 97.53 - 97.95 |
| Close: | 99 - 99.8 | 99.8 - 100.5 |
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Thu, 19 Mar 2026
Why (IRMD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Wed, 18 Mar 2026
Iradimed CEO Susi sells $763k in IRMD stock By Investing.com - Investing.com South Africa
Wed, 18 Mar 2026
iRadimed (NASDAQ:IRMD) CEO Roger Susi Sells 2,500 Shares - MarketBeat
Wed, 18 Mar 2026
Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock - MarketBeat
Wed, 18 Mar 2026
Iradimed Insider Sold Shares Worth $762,971, According to a Recent SEC Filing - marketscreener.com
Wed, 18 Mar 2026
Insider trust linked to IRADIMED (NASDAQ: IRMD) sells 7,500 shares - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 13 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 36.7 (%) |
| Held by Institutions | 60.5 (%) |
| Shares Short | 476 (K) |
| Shares Short P.Month | 454 (K) |
| EPS | 1.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.42 |
| Profit Margin | 26.8 % |
| Operating Margin | 31.2 % |
| Return on Assets (ttm) | 15.7 % |
| Return on Equity (ttm) | 24.7 % |
| Qtrly Rev. Growth | 17 % |
| Gross Profit (p.s.) | 5.05 |
| Sales Per Share | 6.58 |
| EBITDA (p.s.) | 2.13 |
| Qtrly Earnings Growth | 24.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 57.05 |
| PEG Ratio | 0 |
| Price to Book value | 13.43 |
| Price to Sales | 15.15 |
| Price to Cash Flow | 0 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|